Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757167 | PMC |
| http://dx.doi.org/10.3389/fcvm.2024.1528743 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial for "Left Ventricular Hemodynamic Forces Changes in Fabry Disease: A Cardiac Magnetic Resonance Study".
J Magn Reson Imaging
January 2025
ImageWorks LLC, Shaker Heights, Ohio, USA.
Bipolar ablation's safety and efficacy: reassurance coming from ex vivo.
J Interv Card Electrophysiol
January 2025
Division of Cardiovascular Medicine, Section of Cardiac Electrophysiology, Emory University School of Medicine, Atlanta, GA, USA.
Progress with fear of progression post-cardiac valve replacement.
Eur J Cardiovasc Nurs
January 2025
School of Nursing, Queen's University Belfast, Belfast BT9 7BL, UK.
Multisociety endorsement of the 2024 European guideline recommendations on coronary revascularization.
Braz J Cardiovasc Surg
January 2025
Coronary Center, Department of Thoracic and Cardiovascular Surgery, Miller Family Heart, Vascular, & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Aldosterone and Potassium in Heart Failure: Overcoming This Major Impediment in Clinical Practice.
Card Fail Rev
December 2024
Department of Medicine, University of Mississippi Medical Center Jackson, MS, US.
Aldosterone is a key regulator of fluid and electrolyte balance in the body. It is often dysregulated in heart failure (HF) and is a key driver of cardiac remodelling and worse clinical outcomes. Potassium regulation is essential for normal cardiac, gastrointestinal and neuromuscular function.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!